Vulvovaginal candidosis;Vulvovaginalmykosen

Zeitschrift fur Arztliche Fortbildung und Qualitatssicherung

Volumn 92, Issue 3, 1998, Pages 175-179

  Mendling, Werner ^a,b  

^a Klinikum Frankfurt Oder   (Germany)

^b Klinikum Frankfurt/Oder   (Germany)

Author keywords

Candida albicans; Candida glabrata; Epidemiology; Immunology; Treatment; Vaginitis

Indexed keywords

AMOROLFINE; AMPHOTERICIN B; CICLOPIROXOLAMINE; CLOTRIMAZOLE; DEQUALINIUM; ECONAZOLE; FLUCONAZOLE; FLUCYTOSINE; GRISEOFULVIN; ISOCONAZOLE; ITRACONAZOLE; NAFTIFINE; NYSTATIN; TERBINAFINE; TIOCONAZOLE; TOLNAFTATE;

AGE; CANDIDA ALBICANS; CANDIDA GLABRATA; FUNGUS CULTURE; HUMAN; PHASE CONTRAST MICROSCOPY; PREGNANCY; REVIEW; VAGINA CANDIDIASIS; VAGINA SECRETION; VULVA PRURITUS;

ANTIFUNGAL AGENTS; CANDIDIASIS, VULVOVAGINAL; DIAGNOSIS, DIFFERENTIAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFANT, NEWBORN; PREGNANCY; RISK FACTORS; VAGINA;

EID: 0031900614     PISSN: 14317621     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (6)

1. Fidel PL, Ginsburg KA, Cutright JL, Wolf NA, Leaman D, Dunlap K, Sobel JD (1997): Vaginal-Associated Immunitiy in women with recurrent vulvo-vaginal candidiasis: Evidence for vaginal Th 1-Type responses following Intravaginal challenge with Candida antigen. J Inf Dis 176: 728-739
2. Friese K, Mendling W (1996): Therapie der vasinalen Mykosen - oral o. lokal. Gynäkologe 29: 221-228
3. Kunzelmann V, Tietz HJ, Roßner D, Czaika V, Hopp M, Schmalreck A, Sterry W (1996): Voraussetzungen für eine effektive Therapie chronisch rezidivierender Vaginalcandidosen. Mycoses 39 (Suppl 1): 65-72
4. Mendling W (1995): Vaginose, Vaginitis und Zervizitis. Berlin: Springer
5. Mendling W, Koldovsky U (1996): Immunological investigations in vaginal mycoses. Mycoses 39: 177-183
6. Mendling W, Koldovsky U (1996): Investigations by cell-mediated Immunologic Tests and therapeutic trials with Thymopentin in vaginal mycoses, Inf Dis Obstet Gynecol 4: 225-231